HURO PATH Lysis solution (Hemolics) - ARCSA Registration f38c5f85071843aa9b2ac49b648ea256
Access comprehensive regulatory information for HURO PATH Lysis solution (Hemolics) in the Ecuador medical device market through Pure Global AI's free database. This I medical device is registered under ARCSA ID f38c5f85071843aa9b2ac49b648ea256 and manufactured by CELLTRAZONE CO., LTD.. The device was registered on December 07, 2022.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
Free Database
Powered by Pure Global AI
ARCSA Official Data
I
f38c5f85071843aa9b2ac49b648ea256
HURO PATH Lysis solution (Hemolics)
ARCSA ID: f38c5f85071843aa9b2ac49b648ea256
Device Classification
Risk Class
I
Product Type
In Vitro Diagnostic
Brand Name
CelltraZone
Commercial Name
19-633 IVD Reagents/Kits, Cytology/Histology, Stains, Solution
Sterilization Method
METHODOLOGY: HISTOCHEMISTRY AND CYTOCHEMISTRY
Registration Information
Analysis ID
f38c5f85071843aa9b2ac49b648ea256
Registration Date
December 07, 2022
Expiration Date
December 07, 2027
Creation Date
July 12, 2022
Product Use
SOLUCION ACCESORIA PARA HURO PATH SOLUTION (GYN) Y HURO PATH SOLUTION (NO-GYN)
Manufacturer
City
GIMPO-SI
Country
KOREA, REPUBLIC OF
Address
1FLOOR, 6FLOOR, 16, ARAYUK-RO, GOCHON-EUP, GIMPO-SI, GYEONGGI-DO, REPUBLICA DE KOREA
Product Owner
Name
CELLTRAZONE CO., LTD.
Country
KOREA, REPUBLIC OF
Authorized Representative